Jefferies on WAVE Life Sciences (WVE): 'We see reasonable bars for WVE's RNA editor to approach target protein levels'
Jefferies analyst Roger Song reiterated a Buy rating and $28.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)